InventionMed S.A. (WSE:INM)
0.1440
-0.0040 (-2.70%)
At close: Oct 24, 2025
InventionMed Revenue
InventionMed had revenue of 1.58M PLN in the quarter ending June 30, 2025, with 3,285.41% growth. This brings the company's revenue in the last twelve months to 2.01M, up 4,182.88% year-over-year. In the year 2024, InventionMed had annual revenue of 277.76K with 45,810.74% growth.
Revenue (ttm)
2.01M
Revenue Growth
+4,182.88%
P/S Ratio
14.75
Revenue / Employee
401.39K
Employees
5
Market Cap
29.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.76K | 277.16K | 45,810.74% |
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.04B |
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| Celon Pharma | 206.22M |